Abstract: A hybrid powerplant is provided for an aircraft. This hybrid powerplant includes a housing, an electric machine, a machine fluid circuit, a heat engine and a geartrain. The housing includes a machine containment zone and an engine compartment outside of the machine containment zone. The electric machine is arranged within the machine containment zone. The machine fluid circuit services the electric machine. The machine fluid circuit extends in the machine containment zone and is arranged outside of the engine compartment. The heat engine is arranged within the engine compartment. The geartrain is operatively connected to the electric machine and the heat engine.

Abstract: A novel self-cooling food product container apparatus (10) and a process for manufacturing the same is disclosed. A self-cooling food product container (20) combined with a substantive vapor transport system producing a humidification cooling process for cooling food and beverage products P. Methods of assembling and operating the apparatus (10) are also provided.

Abstract: Examples herein provide an approach to enhance an audio mixture of a teleconference application by switching between noise suppression modes using a single model. Specifically, a machine learning (ML) model may be configured to, in response to receiving an audio mixture representation as input, suppress either a background noise of the audio mixture or suppress all noise of the audio mixture except a user's voice. In some examples, the ML model may be trained on speech and background noise training data during a training phase. In addition, the ML model may be trained on a user's voice during an enrollment phase. In addition, during an inference phase, the ML model may enhance the audio mixture by suppressing a portion of the audio mixture.

Abstract: The present invention relates to the finding that certain DPP-4 inhibitors are particularly suitable for treating and/or preventing metabolic diseases, particularly diabetes, in patients with insufficient glycemic control despite a therapy with an oral and/or a non-oral antidiabetic drug.

Abstract: The specification describes the use of selected DPP IV inhibitors for the treatment of physiological functional disorders and for reducing the risk of the occurrence of such functional disorders in at-risk patient groups. In addition, the use of the above-mentioned DPP IV inhibitors in conjunction with other active substances is described, by means of which improved treatment outcomes can be achieved. These applications may be used to prepare corresponding medicaments.

Abstract: A hybrid powerplant is provided for an aircraft. This hybrid powerplant includes a housing, an electric machine, a machine fluid circuit, a heat engine and a geartrain. The housing includes a machine containment zone and an engine compartment outside of the machine containment zone. The electric machine is arranged within the machine containment zone. The machine fluid circuit services the electric machine. The machine fluid circuit extends in the machine containment zone and is arranged outside of the engine compartment. The heat engine is arranged within the engine compartment. The geartrain is operatively connected to the electric machine and the heat engine.

Abstract: Provided are quinazolinone dione compounds for treating cardiac indications such as hypertrophic cardiomyopathy and diastolic dysfunction.

Abstract: A method of operation is provided. During this method, a first power system of an aircraft powerplant is operated to provide a first quantity of power and/or torque to drive rotation of a propulsor rotor. A second power system of the aircraft powerplant is tested during the operating of the first power system. The second power system is configured as or otherwise includes an electric machine. The testing of the second power system includes: signaling the second power system to use the electric machine to provide a second quantity of power and/or torque to further drive the rotation of the propulsor rotor; determining an operational parameter of the aircraft powerplant following the signaling; and evaluating operability of the second power system by comparing the operational parameter to a threshold.

Abstract: A method of operation is provided. During this method, a first power system of an aircraft powerplant is operated to direct a first quantity of fuel into a flowpath of the aircraft powerplant for combustion. A second power system of the aircraft powerplant is tested during the operating of the first power system. The testing of the second power system includes: signaling the second power system to direct a second quantity of fuel into the flowpath for combustion; determining an operational parameter of the aircraft powerplant following the signaling; and evaluating operability of the second power system by comparing the operational parameter to a threshold.

Abstract: A system is provided for an aircraft. This aircraft system includes a propulsor rotor and a powerplant configured to drive rotation of the propulsor rotor. The powerplant includes a turbine section, a flowpath, a first fuel system and a second fuel system fluidly independent of the first fuel system. The turbine section includes a turbine rotor. The flowpath extends through the turbine section from an inlet into the flowpath to an exhaust from the flowpath. The first fuel system is configured to direct first fuel into the flowpath between the inlet and the turbine rotor. The second fuel system is configured to direct second fuel into the flowpath between the inlet and the turbine rotor.

Abstract: The specification describes the use of selected DPP IV inhibitors for the treatment of physiological functional disorders and for reducing the risk of the occurrence of such functional disorders in at-risk patient groups. In addition, the use of the above-mentioned DPP IV inhibitors in conjunction with other active substances is described, by means of which improved treatment outcomes can be achieved. These applications may be used to prepare corresponding medicaments.

Abstract: Real-time low-complexity stereo speech enhancement with spatial cue preservation may be performed. A stereo speech enhancement system receives a stereo input signal (e.g., a left and right input signal). The stereo speech enhancement system estimates spatial cues for a target speaker and downmixes the stereo input signal into a monaural signal. A low-complexity model may then process the monaural signal to generate an enhanced monaural signal. The stereo speech enhancement system upmixes the enhanced monaural signal based on the estimated spatial cues for the target speaker, to generate an enhanced stereo output signal.

Abstract: A heating and cooling apparatus includes a inner container for containing a food product and having a rim and a side wall and a base dome, and an outer container having an open rim and a side wall and a base dome, where the inner container is snugly fitted into the open rim of the outer container and a common lid on the container rims, and the inner container is shorter than the outer container defining a dry gas chamber between the container base domes containing a dry gas and a thermally reactive structure, and where the diameters of the inner container is less than that of the outer container leaving a radial space between the container cylindrical walls defining a humidification liquid chamber containing a humidification liquid, and a sealing member between the dry gas chamber and the humidification liquid chamber.

Abstract: Disclosed are dosage forms comprising a capsule and a fill material, comprising (a) a fill material comprising a dispersion of an active agent and a polymer, the dispersion being granulated, (b) an osmogen, and (c) a glidant. In one embodiment, the dispersion comprises 10 wt % to 90 wt % of the fill material, the osmogen comprises from 5 wt % to 40 wt % of the fill material, and the glidant comprises at least 0.1 wt % of the fill material.

Abstract: The invention relates to a pharmaceutical composition comprising an SGLT2 inhibitor, a DPPIV inhibitor and a third antidiabetic agent which is suitable in the treatment or prevention of one or more conditions selected from type 1 diabetes mellitus, type 2 diabetes mellitus, impaired glucose tolerance and hyperglycemia. In addition the present invention relates to methods for preventing or treating of metabolic disorders and related conditions.

Abstract: The invention relates to a pharmaceutical composition according to the claim 1 comprising an SGLT2 inhibitor and an insulin which is suitable in the treatment or prevention of one or more conditions selected from type 1 diabetes mellitus, type 2 diabetes mellitus, impaired glucose tolerance and hyperglycemia.

Abstract: A hybrid electric propulsion (HEP) system can include a heat engine torque sensor connected between a heat engine and a combining gear box to sense a heat motor input torque input to the combining gear box, an electric motor torque sensor connected between an electric motor and the combining gear box to sense an electric motor input torque input to the combining gear box, and a combining gear box torque sensor connected to an output of the combining gearbox. The system can include a HEP controller operatively connected to each of the heat engine torque sensor, the electric motor torque sensor, and the combining gear box torque sensor to receive one or more torque signals therefrom. The controller can be configured to output one or more output signals as a function of the signals from each of the heat engine torque sensor, the electric motor torque sensor, and the combining gear box torque sensor.

Abstract: A cooling apparatus includes an inner beverage container for containing a food product and having a rim and a side wall and a base dome, and an outer shell container having an open rim and a side wall and a base dome, where the inner beverage container is snugly fitted into the open rim of the outer shell container and a common lid on the container rims, and the inner beverage container is shorter than the outer shell container defining a dry gas chamber between the container base domes containing a dry gas and a cooling structure, and where the diameters of the inner beverage container is less than that of the outer shell container leaving a radial space between the container cylindrical walls defining a humidification liquid chamber containing a humidification liquid, and a deformable barrier between the dry gas chamber and the humidification liquid chamber.

Abstract: A brake disc, also referred to as a rotor, for a disc brake has the function of interacting with a brake lining as a friction partner in the disc brake. The brake disc is formed at least in part of a material having a molybdenum content of ?50 wt. %.

Abstract: The present invention relates to methods for treating and/or preventing podocytes related disorders and/or nephrotic syndrome comprising the administration of an effective amount of a certain DPP-4 inhibitor, as well as to the use of a certain DPP-4 inhibitor for treating and/or preventing a metabolic disease in a patient with or at risk of podocytes related disorders and/or nephrotic syndrome.